Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hartwig Piepenbrock-DZNE Prize: EUR 100,000 for brain researchers

11.09.2013
Prof. Adriano Aguzzi of the University of Zurich and Prof. Charles Weissmann of the Scripps Research Institute Florida (USA) will be awarded the 2013 “Hartwig Piepenbrock-DZNE Prize” for outstanding research in the field of neurodegenerative diseases.

Aguzzi’s and Weissmann’s groundbreaking discoveries on the mechanisms underlying prion diseases have major implications for the understanding of other neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease. The prize is awarded by the Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE). The award ceremony will be held in Berlin on September 24, 2013.

This year the Hartwig Piepenbrock-DZNE prize has a special significance. It marks the company's 100th anniversary and therefore honors the two winners with 100,000 Euro. But 2013 is also the year where special remembrance is given to Hartwig Piepenbrock who forged this company into one of the largest German family firms. He was diagnosed with dementia several years ago and died on July 3. For many years, he was a great benefactor of the arts, science and society. The prize, sponsored by the Piepenbrock Group, recognizes the outstanding research achievements of Profs. Weissmann and Aguzzi. The winners have been selected by an international panel including highly recognized scientists and representatives from the DZNE and the Piepenbrock family.

"The outstanding scientific contributions of Charles Weissmann and Adriano Aguzzi are of extraordinary importance for the entire research field of neurodegenerative diseases," comments Prof. Johannes Dichgans, chairman of the selection committee. "With their prion research they have unveiled previously unknown mechanisms that are crucial for many of these diseases, including Alzheimer’s disease and Parkinson’s disease”. A fundamental aspect of these mechanisms is the accumulation of endogenous, misfolded proteins. The work of Aguzzi and Weissmann provides a solid basis to design new strategies for early diagnosis as well as effective prevention and therapy.

The initial work from Weissmann and Aguzzi provided the most convincing evidence that in prion diseases like BSE or Creutzfeld-Jakob disease an endogenous protein is of central importance. They showed that infective material causes nerve cell death only if this particular protein is present. In subsequent work, the research teams led by Aguzzi and Weissmann clarified fundamental mechanisms by which misfolded proteins, such as prions, could cause toxicity. Work from the Weissmann lab has led to the development of new assays for prion replication and toxicity, as well as characterizing sources of infectivity in humans. Aguzzi and his team went on to reveal how prions propagate from cell to cell and finally invade the brain.

Accumulation of endogenous, misfolded proteins is also at the core of other neurodegenerative disorders including Alzheimer's and Parkinson's diseases. Although the cause of misfolded protein accumulation is not an infection as in some prion diseases, the spread of these proteins from cell to cell and within the nervous system seem to follow similar patterns. There is no evidence that other neurodegenerative diseases such as Alzheimer’s or Parkinson’s disease are contagious. The similarity in the underlying mechanisms of disease progression raises common fundamental research questions and suggests future approaches for prevention, diagnosis and therapy.

The Honorees

Prof. Charles Weissmann (born in 1931) is a Professor Emeritus at the Scripps Research Institute in Florida (USA). The Swiss molecular biologist studied medicine in Zurich and obtained his doctorate in organic chemistry. He completed a postdoctoral fellowship at the School of Medicine of the New York University and subsequently joined the faculty there. In 1967, he returned to the University of Zurich where he assumed the position of Director of the Institute for Molecular Biology. In 1999 he accepted a position with the MRC Prion Unit at the University College London. Five years later he was appointed to the new Scripps Research Institute Florida, where he established and directed the Institute for Infectiology for eight years. Website: http://www.scripps.edu/florida/research/faculty/weissmann

Prof. Adriano Aguzzi (born in 1960) was appointed Director of the Swiss National Reference Center for Prion Diseases at the end of 1995 and has been the Director and a member of the faculty of the Institute for Neuropathology at the University of Zurich since 1997. He obtained his medical degrees in Fribourg and Basel. Following periods at Columbia University, the University of Zurich and the Research Institute for Molecular Pathology in Vienna, he has held the position of Medical Director and Private Lecturer in the fields of pathology and neuropathology at the University of Zurich since 1993. Aguzzi is a citizen of both, Italy and Switzerland. Website: http://www.neuroscience.ethz.ch/research/aging_disorders/aguzzi

About Piepenbrock
The Piepenbrock Group is a fourth generation owner-operated family business. Piepenbrock offers a broad spectrum of services to its customers in the fields of facility management, commercial janitorial services, security and maintenance. Piepenbrock is also a successful packaging machine engineering enterprise. Piepenbrock has a long-established tradition of advocating for the environment, the arts and sports. Aware of the severe impact that neurodegenerative diseases impose on patients, families and caretakers, the Piepenbrock Group has decided to extend their social engagement to the research on neurodegenerative diseases by supporting this research award.
More information:
http://www.piepenbrock.de
http://www.twitter.com/piepenbrock_ug
http://www.youtube.com/user/piepenbrockservice
http://www.xing.com/companies/piepenbrock
About DZNE
The German Center for Neurodegenerative Diseases (DZNE) conducts research into the causes of diseases of the nervous system and develops preventive, therapeutic and care strategies. It is an institute within the Helmholtz Association of German Research Centers with sites in Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen and Witten. The DZNE works in close cooperation with universities, university clinics and non-university research institutions. Website: www.dzne.de / Twitter: http://twitter.com/DZNE_de

Dr. Marcus Neitzert | idw
Further information:
http://www.dzne.de/en/about-us/public-relations/meldungen/2013/press-release-no-26.html

More articles from Awards Funding:

nachricht Extensive Funding for Research on Chromatin, Adrenal Gland, and Cancer Therapy
28.06.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Otto Hahn Medal for Jaime Agudo-Canalejo
21.06.2017 | Max-Planck-Institut für Kolloid- und Grenzflächenforschung

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Ultrathin device harvests electricity from human motion

24.07.2017 | Power and Electrical Engineering

Scientists announce the quest for high-index materials

24.07.2017 | Materials Sciences

ADIR Project: Lasers Recover Valuable Materials

24.07.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>